Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Johannes A. Heijst"'
Autor:
Daphne M. P. Naessens, Judith de Vos, Edo Richard, Micha M. M. Wilhelmus, Cornelis A. M. Jongenelen, Edwin R. Scholl, Nicole N. van der Wel, Johannes A. Heijst, Charlotte E. Teunissen, Gustav J. Strijkers, Bram F. Coolen, Ed VanBavel, Erik N. T. P. Bakker
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Midlife hypertension is an important risk factor for cognitive impairment and dementia, including Alzheimer’s disease. We investigated the effects of long-term treatment with two classes of antihypertensive drugs to determine whether diver
Externí odkaz:
https://doaj.org/article/745f2e184b9840ca9b51d2874d862073
Autor:
Julie van der Post, Jason G. van Genderen, Johannes A. Heijst, Charlotte Blokhuis, Charlotte E. Teunissen, Dasja Pajkrt
Publikováno v:
Viruses, Vol 14, Iss 4, p 671 (2022)
Despite combination antiretroviral therapy (cART), adolescents with perinatally acquired human immunodeficiency virus (PHIV) exhibit cerebral injury and cognitive impairment. Plasma neurofilament light (pNfL) is a biomarker identified as a promising
Externí odkaz:
https://doaj.org/article/1b449b14b8404df883a263082e3845b9
Autor:
Sandra D. Mulder, Robert Veerhuis, Marinus A. Blankenstein, Frans Martens, Philip Scheltens, Cees Mulder, C. Erik Hack, Johannes A. Heijst
Publikováno v:
Mulder, S D, Heijst, J A, Mulder, C, Martens, F, Hack, C E, Scheltens, P, Blankenstein, M A & Veerhuis, R 2009, ' CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease ', Annals of Clinical Biochemistry, vol. 46, pp. 477-483 . https://doi.org/10.1258/acb.2009.009130
Annals of Clinical Biochemistry, 46, 477-483. SAGE Publications Ltd
Annals of Clinical Biochemistry, 46, 477-483. SAGE Publications Ltd
Background Prostate-specific antigen (PSA) is a serine protease that in serum, is predominantly found complexed to the serine protease inhibitor alpha1-antichymotrypsin (ACT). ACT co-localizes with amyloid plaques in Alzheimer's disease (AD) brain an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e28452f997c42d847d4737a045ed688
https://doi.org/10.1258/acb.2009.009130
https://doi.org/10.1258/acb.2009.009130
Autor:
Tatjana E. Vogelvang, Marius J. van der Mooren, Peter Kenemans, Jef J. Emeis, Johannes A. Heijst, Velja Mijatovic
Publikováno v:
American Journal of Obstetrics and Gynecology, 4, 193, 1384-1394
Vogelvang, T E, Mijatovic, V, Kenemans, P, Emeis, J J, Heijst, J A & van der Mooren, M J 2005, ' The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women ', American Journal of Obstetrics and Gynecology, vol. 193, no. 4, pp. 1384-1394 . https://doi.org/10.1016/j.ajog.2005.02.083
American Journal of Obstetrics and Gynecology, 193(4), 1384-1394. Mosby Inc.
Vogelvang, T E, Mijatovic, V, Kenemans, P, Emeis, J J, Heijst, J A & van der Mooren, M J 2005, ' The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women ', American Journal of Obstetrics and Gynecology, vol. 193, no. 4, pp. 1384-1394 . https://doi.org/10.1016/j.ajog.2005.02.083
American Journal of Obstetrics and Gynecology, 193(4), 1384-1394. Mosby Inc.
Objective: To investigate the short-term effects of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis. Study design: In a multicenter, 14-week, randomized, placebo-controlled, double-blind, dose-rangi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab8f043f326fe10c4aa78f4965cd3bd
https://hdl.handle.net/1871/26571
https://hdl.handle.net/1871/26571
Autor:
Charlotte E. Teunissen, Henk J. Groenewegen, Johannes A. Heijst, Wilma D.J. van de Berg, Wesley Jongbloed, Karin van Dijk, Robert Veerhuis, Henk W. Berendse
Publikováno v:
Parkinsonism and Related Disorders, 19(12), 1079-1083. Elsevier BV
van Dijk, K D, Jongbloed, W, Heijst, J A, Teunissen, C E, Groenewegen, H J, Berendse, H W, van de Berg, W D J & Veerhuis, R 2013, ' Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease ', Parkinsonism and Related Disorders, vol. 19, no. 12, pp. 1079-1083 . https://doi.org/10.1016/j.parkreldis.2013.07.016
van Dijk, K D, Jongbloed, W, Heijst, J A, Teunissen, C E, Groenewegen, H J, Berendse, H W, van de Berg, W D J & Veerhuis, R 2013, ' Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease ', Parkinsonism and Related Disorders, vol. 19, no. 12, pp. 1079-1083 . https://doi.org/10.1016/j.parkreldis.2013.07.016
Clusterin is a multifunctional chaperone protein that has repeatedly been linked to Alzheimer's disease (AD) pathogenesis and, more recently, also to Parkinson's disease (PD) by both genetic and proteomic analyses. Although clusterin is detectable in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd4f6032a21a01d6a6694e1642d478f7
https://pubmed.ncbi.nlm.nih.gov/23932065
https://pubmed.ncbi.nlm.nih.gov/23932065
Autor:
Johannes A. Heijst, W.M. van der Flier, Svetlana Hakobyan, B.P. Morgan, R. Veerhuis, Sandra D. Mulder
Publikováno v:
Molecular Immunology, 48(14), 1733-1733. Elsevier Limited
Hakobyan, S, Mulder, S D, Heijst, J A, van der Flier, W M, Morgan, B P & Veerhuis, R 2011, ' Complement regulator factor H (fH) levels in CSF of mild cognitive impairment (MCI) cases depend on the Y402H polymorphism ', Molecular Immunology, vol. 48, no. 14, pp. 1733-1733 . https://doi.org/10.1016/j.molimm.2011.06.433
Hakobyan, S, Mulder, S D, Heijst, J A, van der Flier, W M, Morgan, B P & Veerhuis, R 2011, ' Complement regulator factor H (fH) levels in CSF of mild cognitive impairment (MCI) cases depend on the Y402H polymorphism ', Molecular Immunology, vol. 48, no. 14, pp. 1733-1733 . https://doi.org/10.1016/j.molimm.2011.06.433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4b01914601ef1ff4b73174861e868c
https://research.vumc.nl/en/publications/c05b9b2c-9fe6-4def-ac5f-703b93363814
https://research.vumc.nl/en/publications/c05b9b2c-9fe6-4def-ac5f-703b93363814
